Jin Long Chen Ngm Biopharmaceuticals Inc (NGM) insider trading activity

Jin Long Chen is Chief Scientific Officer of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 972,893 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 64,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 973K

0% 3M change

0% 12M change

Total Value Held $0

JIN-LONG CHEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	BUY Grant, award, or other acquisition	-	64,000 Added 6.17%	972,893 Common Stock
Jan 17 2023	SELL Open market or private sale	$438,172 $5.15 p/Share	85,082 Reduced 8.56%	908,893 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$122,518 $1.44 p/Share	85,082 Added 7.88%	993,975 Common Stock
Dec 07 2021	SELL Open market or private sale	$279,000 $18.6 p/Share	15,000 Reduced 1.62%	908,893 Common Stock
Dec 06 2021	SELL Open market or private sale	$273,150 $18.21 p/Share	15,000 Reduced 1.73%	854,449 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$99,999 $1.44 p/Share	69,444 Added 6.99%	923,893 Common Stock
Nov 15 2021	SELL Open market or private sale	$591,600 $19.72 p/Share	30,000 Reduced 3.34%	869,449 Common Stock
Oct 12 2021	SELL Open market or private sale	$302,100 $20.14 p/Share	15,000 Reduced 1.64%	899,449 Common Stock
Oct 11 2021	SELL Open market or private sale	$306,150 $20.41 p/Share	15,000 Reduced 1.61%	914,449 Common Stock
Sep 14 2021	SELL Open market or private sale	$387,600 $25.84 p/Share	15,000 Reduced 1.59%	929,449 Common Stock
Sep 13 2021	SELL Open market or private sale	$393,750 $26.25 p/Share	15,000 Reduced 1.56%	944,449 Common Stock
Aug 10 2021	SELL Open market or private sale	$347,250 $23.15 p/Share	15,000 Reduced 1.54%	959,449 Common Stock
Aug 09 2021	SELL Open market or private sale	$372,750 $24.85 p/Share	15,000 Reduced 1.52%	974,449 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	$99,999 $1.44 p/Share	69,444 Added 6.56%	989,449 Common Stock
May 03 2021	SELL Open market or private sale	$690,500 $27.62 p/Share	25,000 Reduced 2.65%	920,005 Common Stock
Apr 12 2021	SELL Open market or private sale	$616,250 $24.65 p/Share	25,000 Reduced 2.58%	945,005 Common Stock
Mar 01 2021	SELL Open market or private sale	$666,500 $26.66 p/Share	25,000 Reduced 2.51%	970,005 Common Stock
Feb 16 2021	SELL Open market or private sale	$718,750 $28.75 p/Share	25,000 Reduced 2.45%	995,005 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	$90,000 $0.6 p/Share	150,000 Added 12.82%	1,020,005 Common Stock
Jan 04 2021	SELL Open market or private sale	$744,250 $29.77 p/Share	25,000 Reduced 2.79%	870,005 Common Stock
Dec 14 2020	SELL Open market or private sale	$705,500 $28.22 p/Share	25,000 Reduced 2.72%	895,005 Common Stock
Nov 02 2020	SELL Open market or private sale	$442,500 $17.7 p/Share	25,000 Reduced 2.65%	920,005 Common Stock
Oct 12 2020	SELL Open market or private sale	$425,500 $17.02 p/Share	25,000 Reduced 2.58%	945,005 Common Stock

Also insider at

TNYA

Tenaya Therapeutics, Inc. Healthcare

Director

Jin Long Chen

Chief Scientific Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Value

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

Operation

Value

Type

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Track Activities on NGM

Account